19338005: 2 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

32597014 Two en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442103019 2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

33051000077117 deux fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
deux	Is a	General adjectival modifier	false	Inferred relationship	Some
deux	Is a	nombre	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely ampicillin (as ampicillin trihydrate) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only articaine and epinephrine (medicinal product)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Enalapril and felodipine only product in oral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only lanolin and zinc oxide (medicinal product)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Cetirizine and pseudoephedrine only product	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only articaine and epinephrine in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only morphine and naltrexone (medicinal product)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Benzocaine and trimethobenzamide only product in rectal dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only benzocaine and trimethobenzamide (medicinal product)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Prednisolone and sulfacetamide only product in ocular dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Lanolin and zinc oxide only product in cutaneous dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only prednisolone and sulfacetamide (medicinal product)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only boric acid and salicylic acid (medicinal product)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Carmellose and hydroxyapatite only product	Count of base of active ingredient	False	deux	Inferred relationship	Some
Citric acid and potassium bicarbonate only product in oral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only boric acid and salicylic acid in cutaneous dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Carmellose and hydroxyapatite only product in parenteral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only citric acid and potassium bicarbonate (medicinal product)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only morphine and naltrexone in oral dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Fluorescein stain and oxybuprocaine only product	Count of base of active ingredient	False	deux	Inferred relationship	Some
Enalapril and felodipine only product	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only fluorescein stain and oxybuprocaine in ocular dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength numerator value	False	deux	Inferred relationship	Some	1
Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength numerator value	False	deux	Inferred relationship	Some	1
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely melatonin 2 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength numerator value	False	deux	Inferred relationship	Some	1
Product containing only fluorometholone and sulfacetamide (medicinal product)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Count of base of active ingredient	False	deux	Inferred relationship	Some
Glyceryl trinitrate 2 mg buccal tablet	Has presentation strength numerator value	False	deux	Inferred relationship	Some	1
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Belladonna alkaloid 16.2 mg and opium 30 mg rectal suppository	Count of base of active ingredient	False	deux	Inferred relationship	Some
Hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Fluorometholone and sulfacetamide only product in ocular dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1
Benserazide and levodopa only product in oral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Benserazide 25 mg and levodopa 100 mg oral capsule	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength numerator value	False	deux	Inferred relationship	Some	2
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment	Count of base of active ingredient	False	deux	Inferred relationship	Some
Polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 mg oral capsule	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength numerator value	False	deux	Inferred relationship	Some	1
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only polythiazide and prazosin in oral dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Polythiazide and prazosin only product	Count of base of active ingredient	False	deux	Inferred relationship	Some
Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment	Count of base of active ingredient	False	deux	Inferred relationship	Some
Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Metformin and saxagliptin only product	Count of base of active ingredient	False	deux	Inferred relationship	Some
Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Metformin and saxagliptin only product in oral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Hydrocortisone valerate 2 mg/g cutaneous ointment	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment	Count of base of active ingredient	False	deux	Inferred relationship	Some
Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Coal tar 50 mg/g and pine tar 50 mg/g cutaneous gel	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely olopatadine (as olopatadine hydrochloride) 2 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1
Glyceryl trinitrate 2 mg prolonged-release buccal tablet	Has presentation strength numerator value	False	deux	Inferred relationship	Some	1
Methylphenidate hydrochloride 2 mg/mL oral solution	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1
Ciprofloxacin 2 mg/mL ear solution	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1
Product containing precisely esterified estrogen 1.25 milligram and methyltestosterone 2.5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Diiodohydroxyquinoline 10 mg/mL and hydrocortisone 10 mg/mL cutaneous cream	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely coal tar 60 milligram/1 milliliter and lecithin 4 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely hydrocortisone valerate 2 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1
Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel	Count of base of active ingredient	False	deux	Inferred relationship	Some
Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension	Count of base of active ingredient	False	deux	Inferred relationship	Some
Benzocaine 10 mg/mL and triclosan 2 mg/mL cutaneous spray	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely acetic acid 20 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear solution (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely cetrimide 5 milligram/1 milliliter and chlorhexidine gluconate (as chlorhexidine) 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely nitrofural 2 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1

Start Previous Page 20 of 24 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
32597014	Two	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442102012	2 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442103019	2	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
33051000077117	deux	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module